Sunday, January 19
Home>>New Launch

Category: New Launch
Mutual FundNew Launch

IDFC MF’s Two fixed-income funds

Ecostar Editor MagJuly 8, 2021 2088 Views0

The IDFC Gilt 2027 Index Fund will mature on June 30, 2027, and the IDFC Gilt 2028 Index Fund will mature on April 05, 2028. IDFC Mutual Fund has launched two innovative fixed income open-end funds - the IDFC Gilt 2027 Index Fund and the IDFC Gilt 2028 Index Fund. These are maturity index funds that will invest in government securities and treasury billsthat constitute the CRISIL Gilt 2027 Index and Gilt 2028 Index respectively. Target Maturity Funds have a defined maturity date, unlike regular open-end mutual funds that remain open indefinitely. Upon maturity, the net asset valueof these funds will be paid back to unitholders. Additionally, IDFC's Gilt Index Funds will invest only in sovereign rated instruments - which are guaranteed by the Government of India - thereby reducin...

Read More
Covid-19New Launch

Oral Covid-19 Vaccine on the way

Ecostar Editor MagJuly 8, 2021 2044 Views0

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, with Oramed Pharmaceuticals, announced the development of an oral Covid-19 vaccine that has shown efficacy after a single dose. Premas, Oramed and other shareholders, have formed Oravax Medical, which has received exclusive licenses from Oramed and Premas to develop oral COVID-19 vaccines. After a single dose of the Oravax COVID-19 capsule, efficacy was evident through antibody production in a pilot animal study. Oravax's vaccine promoted both systemic immunity through Immunoglobulin G (IgG), the most common antibody in blood and bodily fluids that protect against viral infections and Immunoglobulin A (IgA) protects the respiratory and gastrointestinal tracts against infection. Premas'protein-based VLP (vir...

Read More
BankingNew Launch

Ujjivan’s women savings account

Ecostar Editor MagJuly 8, 2021 2349 Views0

The account comes with many benefits including interest of up to seven per cent on balance. jjivan Small Finance Bank, Ua part of Ujjivan Financial Services, launched Women Savings Account named Garima Savings Account. The account will offer multiple customised benefits to women including up to seven per cent interest on the savings account. Through the product, the bank aims to serve financially aware and economically active women by being a companion in their day-to-day banking needs. The account offers a higher cashdeposit and free unlimited withdrawal at any of its branches with no additional charges for non home branch transactions. Customers would also enjoy unlimited free NEFT and RTGS transactions through internet banking and mobile banking. The account comes with a persona...

Read More
New Launch

India Medtronic’s TYRX Envelope

Ecostar Editor MagJuly 7, 2021 1709 Views0

TYRX is a value-based offering aimed at lowering infection risk and reducing readmission rates with the long-term goal of creating better outcomes. India Medtronic launched TYRX Absorbable Antibacterial Envelope (TYRX Envelope), an absorbable, single-use, antibacterial envelope designed to stabilize a cardiac implantable electronic device (CIED) or implanted neurostimulator while releasing antimicrobial agents over a minimum of seven days. Constructed from a multifilament, knitted absorbable mesh, the TYRX Envelope holds the CIED device and is fully absorbed by the body approximately nine weeks after implantation. It can be used with any implantable defibrillator, pacemaker, or neurostimulator. Annually in India, 50,000 people with heart conditions receive a CIED, such as a pacemak...

Read More
HealthcareNew Launch

Oral Covid-19 vaccine on the way

Ecostar Editor MagMarch 22, 2021 2427 Views0

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, with Oramed Pharmaceuticals, announced the development of an oral Covid-19 vaccine that has shown efficacy after a single dose. Premas, Oramed and other shareholders, have formed Oravax Medical, which has received exclusive licenses from Oramed and Premas to develop oral COVID-19 vaccines. After a single dose of the Oravax COVID-19 capsule, efficacy was evident through antibody production in a pilot animal study. Oravax’s vaccine promoted both systemic immunity through Immunoglobulin G (IgG), the most common antibody in blood and bodily fluids that protects against viral infections and Immunoglobulin A (IgA) which protects the respiratory and gastrointestinal tracts against infection. Premas’ protein-base...

Read More